EYLIO

EYLIO SAS is a French pharmaceutical company founded in 2019, specializing in supporting biotechnology companies from the discovery of a promising molecule to the completion of clinical trials. EYLIO is authorized by ANSM (French Health Agency for Human Products) and by ANSES (French Health Agency for Veterinary Products) for the release of marketed products and Investigational Products, and for GMP storage under different conditions. EYLIO offers various services, including: - Qualified Person (QP) Services: Batch release, confirmation, and certification of medicinal products for clinical trials or market distribution. - Quality Audits: Assessment of manufacturing sites for active substances and finished products, packaging facilities, warehouses, and quality control laboratories. - Regulatory Expertise: Support for biotechnology laboratories in their regulatory processes, including assistance in the creation and submission of an IMPD (Investigational Medicinal Product Dossier). - Clinical Trial Project Management: Assistance in setting up and managing quality systems for clinical trials. - GMP Storage: Secure and compliant storage of investigational products and market-ready drugs under different temperature conditions. - Secondary Packaging and Labeling for Clinical Trials: EYLIO provides compliant secondary packaging and labeling services tailored to the specific needs of each clinical trial, ensuring traceability, regulatory compliance, and adaptation to the trial protocol requirements.